A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06752356 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

BIOLOGICAL: Immune globulin (human) 10% solution for intravenous administration

Sponsor

Kedrion S.p.A.